This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

8 Apr 2011

AMRI and Parnell Ink Development and Supply Deal

AMRI announced that it has entered into a development and commercial supply agreement with Parnell.

It was announced yesterday that AMRI has signed a development and commercial supply agreement with Parnell Manufacturing Pty Ltd., an Australian company specializing in the research, development and manufacture of veterinary products.


AMRI will provide process development, manufacturing and supply of APIs to support Parnell’s New Animal Drug Application (NADA) with the FDA, as well as the commercial launch of the veterinary product in the U.S.. Development and manufacture of the API will take place at AMRI’s facilities in Albany, NY.

"We are pleased to support Parnell in its introduction of this important veterinary product to the U.S. market,” said AMRI chai

Related News